Abstract
Momordica charantia L. is traditionally used for the management of splenomegaly, although empirical evidence supporting this ethnomedical indication remains limited. This study primarily investigated the traditional fresh leaf/stem infusion and, comparatively, related M. charantia preparations in a cadmium chloride (CdCl2)-induced murine model of splenic injury. Ninety-six Swiss mice were allocated to eight groups, with terminal assessments on Days 1, 7, and 9; CdCl2 was administered on Day 4. Splenic outcomes included absolute and relative spleen mass and qualitative histopathology. Phytochemical profiling was performed by ultra-performance liquid chromatography coupled to high-resolution mass spectrometry (UPLC-HRMS), and radical-scavenging activity was assessed using ABTS and DPPH assays. At Day 9, the traditional fresh leaf/stem infusion showed the strongest and most consistent treatment-associated signal, with lower relative and absolute spleen masses than the CdCl2-exposed disease control. Several other preparations showed numerical reductions in absolute spleen mass but did not meet multiplicity-adjusted significance thresholds. UPLC-HRMS revealed diverse features consistent with triterpenoid-, glycoside-, sterol-, and oxygenated lipid-related natural-product classes. These exploratory findings provide experimental support for further investigation of the traditional fresh leaf/stem infusion, while not establishing clinical efficacy against human splenomegaly.